<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ami_virus_3\PMC7252634\results\search\tropicalVirus\results.xml">
  <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
  <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
  <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
  <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Genetics: Mutagenesis"/>
  <result pre="residues onto the surface of the structure of the related" exact="CHIKV" post="E1/E2 heterodimer (PDB 3N42) [26], we found that most"/>
  <result pre="(C) Loss-of-binding residues mapped onto the crystal structure of the" exact="CHIKV" post="E1/E2 heterodimer (PDB 3N42), with three heterodimers subunits combined"/>
  <result pre="domain (green) and C domain (magenta) when overlaid on the" exact="CHIKV" post="E1/E2 trimer, whereas those in the second group (orange)"/>
  <result pre="group as determined through alanine scanning mutagenesis mapped onto the" exact="CHIKV" post="E1/E2 trimer of heterodimers (PDB 3N42). Space-filling models for"/>
  <result pre="Mxra8 binding to cell-surface-displayed chikungunya proteins are mapped onto the" exact="CHIKV" post="E1/E2 trimer of heterodimers (PDB 3J2W) in red, and"/>
  <result pre="cell surface protein Mxra8 was identified as a receptor for" exact="CHIKV" post="and several other arthritogenic alphaviruses, including RRV, Mayaro, and"/>
  <result pre="and B domain. We overlaid these residues (yellow) on the" exact="CHIKV" post="E1/E2 heterodimer along with the known Mxra8 contact residues"/>
  <result pre="range to the best-in-class human neutralizing antibodies for the related" exact="CHIKV" post="[22]. For nearly half of these RRV mAbs, a"/>
  <result pre="could affect mAb binding to domain B allosterically. Previously, neutralizing" exact="CHIKV" post="antibodies have been shown to target analogous sites within"/>
  <result pre="protein that resulted in loss of Mxra8 binding to cell-surface-displayed" exact="CHIKV" post="proteins are residues 62â€&quot;64, 71â€&quot;72, and 74â€&quot;76 [25,28,29], which"/>
  <result pre="tissues examined. A combination mAb therapy has proven efficacious for" exact="CHIKV" post="[24], so it is possible that pairing antibodies such"/>
  <result pre="a protective effect when administered prophylactically, as was seen with" exact="CHIKV" post="mAb studies [22,24,40]. While the market for an RRV"/>
  <result pre="therapy has already shown promise in mice and macaques for" exact="CHIKV" post="[42,43]. A future challenge that must be addressed before"/>
  <result pre="Biotek plate reader. A similarly prepared human mAb specific for" exact="Zika" post="virus (ZIKV-117 [47]) was included as a negative control"/>
  <result pre="SamI-C. Characterisation of mouse monoclonal antibodies targeting linear epitopes on" exact="Chikungunya" post="virus E2 glycoprotein. J Virol Methods. 2014;195: 126â€&quot;133. 10.1016/j.jviromet.2013.10.01524134938"/>
  <result pre="al.Development of a highly protective combination monoclonal antibody therapy against" exact="Chikungunya" post="virus. PLoS Pathog. 2013;9: e100331210.1371/journal.ppat.100331223637602 25ZhangR, KimAS, FoxJM, NairS,"/>
  <result pre="26VossJE, VaneyM-C, DuquerroyS, VonrheinC, Girard-BlancC, CrubletE, et al.Glycoprotein organization of" exact="Chikungunya" post="virus particles revealed by X-ray crystallography. Nature. 2010;468: 709â€&quot;712."/>
  <result pre="FernandezE, KoseN, BinCao, FoxJM, BombardiRG, et al.Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in mice. Nature. 2016;540:"/>
 </snippets>
</snippetsTree>
